These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Ziprasidone (Geodon) for schizophrenia. Med Lett Drugs Ther; 2001 Jun; 43(1106):51-2. PubMed ID: 11402259 [No Abstract] [Full Text] [Related]
3. Haloperidol and Ziprasidone for Treatment of Delirium in Critical Illness. Girard TD; Exline MC; Carson SS; Hough CL; Rock P; Gong MN; Douglas IS; Malhotra A; Owens RL; Feinstein DJ; Khan B; Pisani MA; Hyzy RC; Schmidt GA; Schweickert WD; Hite RD; Bowton DL; Masica AL; Thompson JL; Chandrasekhar R; Pun BT; Strength C; Boehm LM; Jackson JC; Pandharipande PP; Brummel NE; Hughes CG; Patel MB; Stollings JL; Bernard GR; Dittus RS; Ely EW; N Engl J Med; 2018 Dec; 379(26):2506-2516. PubMed ID: 30346242 [TBL] [Abstract][Full Text] [Related]
4. Blonanserin in the treatment of delirium. Kato K; Yamada K; Maehara M; Akama F; Kimoto K; Saito M; Yano H; Ichimura A; Matsumoto H Psychiatry Clin Neurosci; 2011 Jun; 65(4):389-91. PubMed ID: 21569175 [TBL] [Abstract][Full Text] [Related]
5. Intravenous ziprasidone for treatment of delirium in the intensive care unit. Young CC; Lujan E Anesthesiology; 2004 Sep; 101(3):794-5. PubMed ID: 15329607 [No Abstract] [Full Text] [Related]
6. Focus on ziprasidone. Green B Curr Med Res Opin; 2001; 17(2):146-50. PubMed ID: 11759185 [TBL] [Abstract][Full Text] [Related]
7. Free your MIND and the rest will follow: decoding delirium in the intensive care unit. Balas MC Crit Care Med; 2010 Feb; 38(2):697-8. PubMed ID: 20083930 [No Abstract] [Full Text] [Related]
8. Case of delirium complicated with pneumonia that improved with blonanserin administration. Andoh H; Kato K; Sato R; Akama F; Sakaguchi T; Matsumoto H Psychiatry Clin Neurosci; 2010 Oct; 64(5):588-9. PubMed ID: 20923437 [No Abstract] [Full Text] [Related]
9. [Ziprasidone and dementia]. Aakhus E Tidsskr Nor Laegeforen; 2004 Aug; 124(16):2155-6; author reply 2155-6. PubMed ID: 15334150 [No Abstract] [Full Text] [Related]
10. Ziprasidone: efficacy and safety in patients with bipolar disorder. Patel NC; Keck PE Expert Rev Neurother; 2006 Aug; 6(8):1129-38. PubMed ID: 16893341 [TBL] [Abstract][Full Text] [Related]
11. Antipsychotics for the prevention and treatment of delirium in the intensive care unit: what is their role? Devlin JW; Skrobik Y Harv Rev Psychiatry; 2011; 19(2):59-67. PubMed ID: 21425934 [TBL] [Abstract][Full Text] [Related]
17. Switching among antipsychotics in everyday clinical practice: focus on ziprasidone. Rossi A; Cañas F; Fagiolini A; Larmo I; Levy P; Montes JM; Papageorgiou G; Sturlason R; Zink M; Correll CU Postgrad Med; 2011 Jan; 123(1):135-59. PubMed ID: 21293094 [TBL] [Abstract][Full Text] [Related]
18. Sudden death in a patient with Tourette syndrome during a clinical trial of ziprasidone. Scahill L; Blair J; Leckman JF; Martin A J Psychopharmacol; 2005 Mar; 19(2):205-6. PubMed ID: 15728441 [No Abstract] [Full Text] [Related]
19. Three cases of schizophrenia showing improvement after switching to blonanserin. Kurotaki N; Nobata H; Nonaka S; Nishihara K; Ozawa H Psychiatry Clin Neurosci; 2011 Jun; 65(4):396-7. PubMed ID: 21682816 [No Abstract] [Full Text] [Related]
20. Ziprasidone in Huntington's disease: the first case reports. Bonelli RM; Mayr BM; Niederwieser G; Reisecker F; Kapfhammer HP J Psychopharmacol; 2003 Dec; 17(4):459-60. PubMed ID: 14870962 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]